NCT06908252

MAPS PrEP Van Study

Integrating PrEP Into Mobile Addiction Treatment and Primary Care Services

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Duke University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.

Detailed description

The purpose of this study is to evaluate a pilot program that provides Pre-Exposure Prophylaxis (PrEP) for people who use drugs (PWUD) and are at risk for contracting HIV. Given the ongoing overdose crisis and the risk of HIV among PWUD, this study aims to assess weather offering oral PrEP on a Medical Mobile Unit (MMU) is a viable strategy for preventing HIV transmission in high-risk populations. The other goal of this study is to assess community perceptions of PrEP and perceived HIV risk among Syringe Service Program (SSP) clients visiting a MMU.

Conditions

• HIV Infection

Interventions

Type	Name	Description
DRUG	Pre-Exposure Prophylaxis (PrEP)	Oral Pre-Exposure Prophylaxis (PrEP) pills

Timeline

• Start date: 2025-09-17
• Primary completion: 2026-06-30
• Completion: 2026-07-31
• First posted: 2025-04-03
• Last updated: 2026-01-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study